- Home
- SDGR vs BSTZ Comparison
SDGR vs BSTZ Comparison
Compare SDGR & BSTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDGR
- BSTZ
- Stock Information
- Founded
- SDGR 1990
- BSTZ 2019
- Country
- SDGR United States
- BSTZ United States
- Employees
- SDGR N/A
- BSTZ N/A
- Industry
- SDGR Biotechnology: Pharmaceutical Preparations
- BSTZ Trusts Except Educational Religious and Charitable
- Sector
- SDGR Health Care
- BSTZ Finance
- Exchange
- SDGR Nasdaq
- BSTZ Nasdaq
- Market Cap
- SDGR 1.7B
- BSTZ 1.5B
- IPO Year
- SDGR 2020
- BSTZ N/A
- Fundamental
- Price
- SDGR $20.32
- BSTZ $20.87
- Analyst Decision
- SDGR Buy
- BSTZ
- Analyst Count
- SDGR 7
- BSTZ 0
- Target Price
- SDGR $28.43
- BSTZ N/A
- AVG Volume (30 Days)
- SDGR 1.4M
- BSTZ 303.2K
- Earning Date
- SDGR 08-06-2025
- BSTZ 01-01-0001
- Dividend Yield
- SDGR N/A
- BSTZ 8.31%
- EPS Growth
- SDGR N/A
- BSTZ N/A
- EPS
- SDGR N/A
- BSTZ 0.71
- Revenue
- SDGR $237,917,000.00
- BSTZ N/A
- Revenue This Year
- SDGR $24.44
- BSTZ N/A
- Revenue Next Year
- SDGR $22.17
- BSTZ N/A
- P/E Ratio
- SDGR N/A
- BSTZ $26.69
- Revenue Growth
- SDGR 18.59
- BSTZ N/A
- 52 Week Low
- SDGR $16.60
- BSTZ $14.11
- 52 Week High
- SDGR $28.47
- BSTZ $19.43
- Technical
- Relative Strength Index (RSI)
- SDGR 51.18
- BSTZ 44.27
- Support Level
- SDGR $18.75
- BSTZ $20.49
- Resistance Level
- SDGR $20.37
- BSTZ $21.62
- Average True Range (ATR)
- SDGR 1.07
- BSTZ 0.26
- MACD
- SDGR 0.11
- BSTZ -0.15
- Stochastic Oscillator
- SDGR 96.23
- BSTZ 25.00
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
About BSTZ BlackRock Science and Technology Term Trust of Beneficial Interest
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.